KDM1A and neoplasm: As a direct regulator of SOX2, which is a lineage-survival oncogene of LSCC,40 inhibition of LSD1 is regarded as a promising treatment strategy for LSCC.38 Recently, studies have also found that this epigenetic regulator is important in regulating tumor immunity (Fig. 6e).